Latest Breaking News On - Stefan riley - Page 4 : comparemela.com

Inozyme Pharma, Inc. Announces Proposed Offering of Common Stock

Inozyme Pharma, Inc. Announces Pricing of Public Offering of Common Stock

BOSTON, July 27, 2023 Inozyme Pharma, Inc. , a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal.

Inozyme Pharma, Inc. Announces Proposed Offering of Common

BOSTON, July 27, 2023 (GLOBE NEWSWIRE) Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare disease biopharmaceutical company developing novel.

Inozyme Pharma Announces Updates on Global Development Strategy of INZ-701 for the Treatment of ...

- Change in plasma pyrophosphate (PPi) as primary endpoint in the U.S. and co-primary endpoint in the EU for planned ENERGY-3 pivotal trial in pediatric patients -

Inozyme Pharma to Provide ENPP1 Deficiency Program Update on July 26, 2023